INNP FINRA deleted symbol:

http://otce.finra.org/DLDeletions

Anything, something???

Innolife Pharma, Inc. (INNP) of Toronto, Ontario;

The Commission temporarily suspended trading in the securities of the 17 companies because of questions that have been raised about the accuracy and adequacy of publicly disseminated information concerning their status as publicly-traded companies.

SECURITIES EXCHANGE ACT OF 1934 Release No. 60707 / September 23, 2009

The Securities and Exchange Commission (the "Commission") announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the "Exchange Act"), of trading in the securities of the following 17 companies at 9:30 a.m. EDT on September 23, 2009, and terminating at 11:59 p.m. EDT on October 6, 2009:

AEI Transportation Holdings, Inc. (DTGP) of Seattle, Washington;
The Alcar Chemicals Group, Inc. (ALCX) of Vercheres, Quebec;
China Adnet Enterprises, Inc. (CAEJ) of New York, New York;
Innolife Pharma, Inc. (INNP) of Toronto, Ontario;
KSW Industries, Inc. (KSWJ) of Etobicoke, Ontario;
Level Vision Electronics, Inc. (LVLV) of Montreal, Quebec;
Life Exchange, Inc. (LFXG) of Miami, Florida;
Lotta Coal, Inc (LCOL) of Calgary, Alberta;
Magellan Energy Ltd. (MGLG) of Mississauga, Ontario;
Marinas International, Inc. (MNSI) of Cincinnati, Ohio;
Microlink Solutions, Inc. (PKTO) of Calgary, Alberta;
UDS Group, Inc. (UDSG) of Boca Raton, Florida;
United Environmental Energy Corp. (UTEM) of Fort Lauderdale, Florida;
Uptrend Corp. (UPCP) of Shinjingshan District, Beijing;
VShield Software Corp. (VSHE) of Henderson, Nevada,
World Hockey Association Corp. (WHKA) of Oldsmar, Florida; and
WW Energy, Inc. (WWNG) of Farmington, New Mexico.

The Commission temporarily suspended trading in the securities of the 17 companies because of questions that have been raised about the accuracy and adequacy of publicly disseminated information concerning their status as publicly-traded companies. Specifically, certain persons appear to have either: 1) usurped the identity of defunct or inactive publicly traded corporations, initially by incorporating new entities using the same names as each of the defunct entities, or 2) reinstated defunct publicly traded corporations without authorization.

The Commission cautions brokers, dealers, shareholders, and prospective purchasers that they should carefully consider the foregoing information along with all other currently available information and any information subsequently issued by the suspended companies.

Further, brokers and dealers should be alert to the fact that, pursuant to Rule 15c2-11 under the Exchange Act, at the termination of the trading suspension, no quotation may be entered unless and until they have strictly complied with all of the provisions of the rule. If any broker or dealer has any questions as to whether or not he has complied with the rule, he should not enter any quotation but immediately contact the staff in the Division of Trading and Markets, Office of Interpretation and Guidance, at (202) 5515777. If any broker or dealer is uncertain as to what is required by Rule 15c2-11, he should refrain from entering quotations relating to the securities of any of the foregoing 17 companies until such time as he has familiarized himself with the rule and is certain
that all of its provisions have been met. If any broker or dealer enters any quotation which is in violation of the rule, the Commission will consider prompt enforcement action.
If any broker dealer or other person has any information that may relate to this matter, it or he should contact John Polise, Assistant Director, Division of Enforcement by calling 202-551-4600 or sending an email to ENF17suspensions@sec.gov.

http://www.sec.gov/litigation/suspensions/2009/34-60707.pdf

What happend to Rita!!!!!!!!!!!

despite the lack of either volume or chatter, the chart looks poised. and the support on L2 is rising. there are now 4 mm's at or above .05. a trade at the current ask will break the year high of .063.

take a look at the sixth month weekly. this is thin and someone has been nibbling. any kind of pressure at the top and it could go.

a bid break of .08 would be very strong.

good luck to ALL

rich

Looks like somebody has been buying the past few days, I guess they new about todays news.
http://biz.yahoo.com/prnews/080826/to255.html?.v=68

NEW SITE
http://www.innolifepharma.com/index.html

Press Release Source: Innolife Pharma Inc.

Innolife Pharma Inc. Announces The Launching Of A New And Improved Website
Wednesday May 28, 7:30 am ET

MARKHAM, ON, May 28 /PRNewswire-FirstCall/ - Innolife Pharma, Inc. (Other OTC:INNP.PK - (http://innp.pk/) - News) is pleased to announce that they have unveiled their new website. This new look should give investors and potential clients a much more comfortable feeling with regards to what INNP is trying to accomplish in their future endeavors.

ADVERTISEMENT
About Innolife Pharma Inc.

--------------------------

Innolife Pharma Inc. (PINKSHEETS: INNP - News) is a small publicly traded specialty multi-discipline medical group focusing on licensing the Natural Pain Relief Center all-natural proprietary breakthrough in the treatment of chronic pain.

FORWARD-LOOKING STATEMENTS:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.


Source: Innolife Pharma Inc.

The PR seemed to have little effect on the price of INNP. If there was really something there the people who should know would have pushed the price up. There was hardly and volume over the past two weeks. Not a good sign.

HERE WE GO!!!
Press Release Source: Innolife Pharma Inc.

Innolife Pharma Inc. acquires rights to breakthrough in non-narcotic chronic pain treatment
Tuesday May 20, 7:30 am ET
Relief soon to be widely available for chronic pain sufferers.

MARKHAM, ON, May 20 /PRNewswire-FirstCall/ - Innolife Pharma, Inc. (Other OTC:INNP.PK - News) is pleased to announce that it has acquired North American licensing rights to the Natural Pain Relief Center non-narcotic proprietary breakthrough in the treatment of chronic pain.

ADVERTISEMENT
Today, one in five Americans suffer with chronic pain (~ 60 million adults) spending approximately $120 Billion a year and the aging baby boomers have reported in surveys more aches and pains than any previous generation.

New Medical Finding with Brain Scans and Functional MRI's

Modern Brain Imaging has revealed that most chronic pain is the result of the brain's inability to turn off pain messages from the body. In chronic pain the brain simply is not producing and releasing enough natural pain killers (such as endorphins) to stop the person's suffering. These new medical findings show that chronic pain sufferers from headaches, migraines, fibromyalgia, back pain, sciatica, arthritis or a combination of all of them, are caused by a low level of Natural Pain Killer's (such as Endorphins and others) in the brain, as compared to people without chronic pain.

Over three years of in-clinic testing showed that this breakthrough all-natural program relieved significant chronic pain in 8 out of 10 people and with sustainable results. This non-narcotic, combination treatment has been receiving accolades from chronic pain sufferers with major improvement in mood and energy and dramatic decreases in pain levels, allowing a return to normal life function.

Innolife Pharma Inc. has an aggressive growth plan in place with a projected target of 95 licensed clinics in 3 years with projected top line annual revenue in excess of $30 million and a projected bottom line profit of over $12 million annually (40+%).

With the aging demographic, chronic pain is becoming a larger and larger international epidemic. Innolife Pharma Inc. is positioned to be the leading service provider in this segment - with a business model that is designed to provide excellent operating margins and tremendous growth for many years to come.

About Innolife Pharma Inc.

Innolife Pharma Inc. (PINKSHEETS: INNP - News) is a small publicly traded specialty multi-discipline medical group focusing on licensing the Natural Pain Relief Center all-natural proprietary breakthrough in the treatment of chronic pain.

FORWARD-LOOKING STATEMENTS:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.


Source: Innolife Pharma Inc.

Still have some shares of this...just waiting for dilution...if we don't get any I'd be STOKED! W/O dilution $1-2 is possible...having said that I only have about 5000 shares from wayyyy back.

Maxwell Media Marketing: Real Stock Discoveries Movers and Shakers for Monday, May 12, 2008 INNP, GWGI, CNEX, BELM, RADN, CMTL

Monday , May 12, 2008 12:20ET

http://www.knobias.com/story.htm?eid=3.1.9221cd9bfb201d967d2c8b2fc5acead3f26b2fcb353319a429911c1e72c5c0f9

May 12, 2008 (M2 PRESSWIRE via COMTEX) -- Maxwell Media Marketing's Real Stock Discoveries Market Movers and Shakers for today and tomorrow are: Innolife Pharma, Inc. (Pink Sheets: INNP), Galloway Energy Inc. (Pink Sheets: GWGI), Cannon Exploration Inc. (Pink Sheets: CNEX), Bell Microproducts Inc. (Pink Sheets: BELM), Radyne Corporation (NasdaqGS: RADN), Comtech Telecommunications Corp (NasdaqGS: CMTL)

Visit http://www.realstockdiscoveries.com and register for our regular newsletter and email alerts. While there check out our featured companies, always of interest to serious speculators everywhere. Currently our clients feature Asia, information technology and wireless internet, all hot sectors.

Also visit our blog at http://www.serious-speculator.com/blog. There you will find updates on our featured companies along with interesting and entertaining comments on the markets and economies.

Our Daily Movers and Shakers are posted daily at http://www.realstockdiscoveries.com/movers.htm.

Stop by and bookmark the page so you never miss these timely notices of companies on the move.

MOVERS AND SHAKERS:

INNOLIFE PHARMA, INC. - Product acquisition.

Innolife Pharma, Inc. (Pink Sheets: INNP) is trading up 267% on heavy volume on the news of May 12, 2008 that the Company has been in discussion over the previous eight months regarding the formation of a joint venture partnership. INNP has reached a point in these negotiations where final written terms have been submitted on all key issues which could lead to the Company's very first product acquisition. It should be noted that this process evolved methodically over this extended period due to the successful, long term history of the product involved, and the well-established reputation of its founding corporation. To read the entire story, click here: http://biz.yahoo.com/prnews/080512/to284.html?.v=71 GALLOWAY ENERGY INC. - New Director, Gold on the rise.

Galloway Energy Inc. (Pink Sheets: GWGI) is trading up 195% on early trading on the news of Friday, May 09, 2008 announcing that Francis D.A. Forbes III has agreed to represent the company on its Board of Directors. The addition of Mr. Forbes will serve the company's need for expansion into the North American mineral markets as he specializes in introducing companies to Mexico. To read the entire story, click here: http://biz.yahoo.com/iw/080509/0395691.html CANNON EXPLORATION INC. - More Gold News.

Cannon Exploration Inc. (Pink Sheets: CNEX) is trading up 12% on early trading on the news of May 12, 2008 that it has entered into a Letter of Intent (LOI) agreement with IPMG Inc., an Ontario mineral resource exploration company, whereby IPMG has agreed to grant to Cannon Exploration Inc. an option to purchase up to 100% interest in the old "Queen Alexandria" gold mine, located in Northern Ontario. To read the entire story, click here: http://biz.yahoo.com/iw/080512/0395890.html BELL MICROPRODUCTS INC. - Accounting adjustments.

Bell Microproducts Inc. (Pink Sheets: BELM) is trading up 18% on early trading on the news of May 12, 2008 that announced the completion of the independent review of certain historical accounting practices conducted by a special committee of the Board of Directors. As previously announced, the special committee was appointed to review the Company's historical accounting treatment for certain reserves, accruals and other accounting estimates reflected in its previously reported financial statements for the years 2004 and 2005 and the first two quarters of 2006. This review was in addition to the previously-announced independent investigation of historical stock option practices. To read the entire story, click here: http://biz.yahoo.com/pz/080512/142474.html RADYNE CORPORATION and COMTECH TELECOMMUNICATIONS CORP - Merger news

Radyne Corporation (NasdaqGS: RADN) is trading up 18% on the news of May 12, 2008 that announced the signing of a definitive merger agreement with Comtech Telecommunications Corp (NasdaqGS: CMTL) pursuant to which Comtech has agreed to acquire Radyne in an all-cash transaction. To read the entire story, click here: http://biz.yahoo.com/pz/080512/142467.html ABOUT REAL STOCK DISCOVERIES

Real Stock Discoveries is an Internet destination for investors seeking information on MicroCap and NanoCap companies. Our web site features companies we believe merit attention and includes Research Reports authored by our financial writers. We publish a newsletter to our subscribers, and we publish our "Movers and Shakers Alert" on a regular basis which we send out on the M2 Presswire from time to time identifying active and interesting MicroCap and NanoCap companies. To feature a company on our web site or in our newsletter or our Movers and Shakers Alert, contact CB Maxwell at 209-533-8291 or email info@realstockdiscoveries.com.

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The Real Stock Discoveries employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using you agree to hold Real Stock Discoveries, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. Real Stock Discoveries encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Real Stock Discoveries makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. Real Stock Discoveries and its affiliates are not registered investment advisors or broker dealers. Real Stock Discoveries has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. Real Stock Discoveries also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Real Stock Discoveries makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through Real Stock Discoveries. Real Stock Discoveries owners may or may not hold positions in the companies that are profiled. For more information on compensation and for a more detailed disclaimer please visit this link: www.realstockdiscoveries.com/disclaimer.htm

The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.

Compensation - For more information, please visit our disclaimer at http://www.realstockdiscoveries.com/disclaimer.htm.

Third Party Web Sites and Information:

Real Stock Discoveries and newsletter may provide hyperlinks to third party websites or access to third party content. Real Stock Discoveries does not control, endorse, or guarantee content found in such sites. You agree that Real Stock Discoveries is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that Real Stock Discoveries shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

CONTACT: CB Maxwell, Publisher, Real Stock Discoveries Tel: +1 209 533 8291 e-mail: info@realstockdiscoveries.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

(C)1994-2008 M2 COMMUNICATIONS LTD


Public Companies Associated with this story:
BELM CMTL CNEX GWGI INNP
RADN

Knobias Subject Codes Associated with this story:
Major Agreements

Content transmitted by Knobias.com Copyright © 2008 Visit Knobias.com

http://www.knobias.com/story.htm?eid=3.1.9221cd9bfb201d967d2c8b2fc5acead3f26b2fcb353319a429911c1e72c5c0f9

ABOUT | PARTNERS | ADVERTISING INFO | CONTACT US | COPYRIGHT | PRIVACY | LEGAL | DISCLAIMER
Copyright © 2008 Knobias.Com, LLC. All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Knobias.Com, LLC, nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Knobias.Com website(s), a user agrees not to redistribute the information found therein. Knobias.Com, LLC is not a registered broker-dealer and does not endorse or recommend any securities listed herein or any services of any brokerage company.

OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Monday, May 12th CABN, LLEG, INNP, CYPW, DLKM
Monday , May 12, 2008 12:42ET

http://www.knobias.com/story.htm?eid=3.1.9b3470af7ce5d6c4bb9fee0ab0c97c290e51531daed3bce9e7b1b06e9ede7404

May 12, 2008 (M2 PRESSWIRE via COMTEX) -- Our Stocks to Watch today include Carbon Sciences Inc. (OTCBB: CABN), Laidlaw Energy Group Inc. (OTC: LLEG), Innolife Pharma Inc. (OTC: INNP), Cyclone Power Technologies Inc. (OTC: CYPW), Douglas Lake Minerals (OTCBB: DLKM)

Visit http://www.otcpicks.com to register for our Daily Market Mover's Digest Newsletter and Email Stock Watch Alerts.

CARBON SCIENCES INCORPORATED (OTCBB: CABN) "Up 5.88% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CABN.php

Company Profile: http://www.otcpicks.com/carbon-sciences/carbon-sciences-2.htm Carbon Sciences, Inc. focuses on developing GreenCarbon technology to convert carbon dioxide into a form that would not contribute to global warming. Its GreenCarbon technology is targeted at coal-fired electrical power plants and fuel production plants. The company was founded in 2006 as Zingerang, Inc. and changed its name to Carbon Sciences, Inc. in April 2007. Carbon Sciences, Inc. is based in Santa Barbara, California.

CABN News:

May 12 - Carbon Sciences Targets Near Term Multi-Billion Dollar Market for Its CO2 Transformation Technology

Carbon Sciences, Inc. (OTCBB: CABN), the developer of a breakthrough technology to transform harmful carbon dioxide (CO2) into high value, earth-friendly products, today announced its first application targeting a near term multi-billion dollar global market.

This initial application of the Company's technology is a process that will transform CO2 into a high value chemical compound, currently used in the manufacture of paper, pharmaceuticals and plastics. Unlike existing methods of production, Carbon Sciences' clean tech process will be carbon neutral, use less energy and result in a lower cost product.

The demand for this high value chemical compound (Precipitated Calcium Carbonate or "PCC") is projected to grow to 10 million tons by 2010, due to increased global paper consumption and construction in Asian countries. Of the forecasted total, approximately 70% of the PCC produced is expected to be used by the paper industry as brightness coating and filler.

The Company's management believes that energy and CO2 intensive industries, such as paper production, will welcome this innovative clean technology because it offers two very important benefits - lower cost and carbon neutrality. For example, a paper mill with an integrated PCC plant, based on the Company's proprietary technology, will be able to transform its own CO2 emissions into PCC for immediate use in paper production - thereby decreasing cost and CO2 emissions.

Commenting on Carbon Sciences' go-to-market strategy, Derek McLeish, the Company's CEO, said, "We are excited that the PCC market provides us with a lucrative near term opportunity. While the massive market for CO2 mitigation in coal-fired power plants may be years away, the multi-billion dollar PCC market is here and now."

Mr. McLeish further stated, "According to the International Energy Agency, the CO2 mitigation technology market is projected to reach $400 billion by 2030. In April 2008, for the first time in history, President Bush unveiled a climate change proposal suggesting that the U.S. would accept binding cuts on CO2 emissions and calling for a peak by 2023, starting with the power generation industry. We believe that by focusing our efforts on the existing multi-billion dollar PCC industry, we will be well positioned to be a major player in the even larger $400 billion CO2 mitigation market in the future. This strategy is in line with our corporate mission of enabling a carbon neutral world by transforming CO2 into high value products, one industry at a time."

LAIDLAW ENERGY GROUP (OTC: LLEG) "Up 28.57% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/LLEG.php

Laidlaw Energy is engaged in the development of independent power plants that generate electricity from renewable resources, with a particular emphasis on biomass power. Laidlaw Energy's mission is to build and manage a profitable portfolio of biomass facilities through the development of new facilities and acquisition of existing facilities, and in so doing become the leading supplier of biomass power in the United States. Laidlaw Energy is headquartered in New York, New York. For more information, visit www.LaidlawEnergy.com.

LLEG News:

May 12 - Laidlaw Energy Signs Definitive Agreement for the Purchase of New Hampshire Facility

Laidlaw Energy Group, Inc. (OTC: LLEG), through its affiliate, Laidlaw Berlin BioPower, LLC ("Laidlaw"), announced that it has entered into a definitive agreement (the "Agreement") with North American Dismantling Corp. ("NADC") to acquire the assets comprising the former Fraser Papers pulp mill located in Berlin, NH. In connection with the execution of the Agreement, Laidlaw has provided a significant "hard money" deposit to NADC in anticipation of the closing of the acquisition.

Commenting on the signing of the Agreement with Laidlaw, NADC President, Rick Marcicki, stated "We are very pleased to have reached this agreement with Laidlaw. Having worked with the principals of Laidlaw on this transaction for more than a year, I feel confident that they are the right company to execute this innovative plan for the conversion of the former Fraser pulp mill to a highly advanced biomass energy plant."

While the Agreement provides for up to 90 days for the closing of the acquisition, the parties anticipate that the closing will occur much sooner. As discussed in a news release dated 4-1-08, Laidlaw has entered into an agreement with HH Capital Advisors, LLC (www.hhcapital.com) for all of the requisite financing for the acquisition and development of the largest and most environmentally advanced biomass energy facility in the U.S. at the Berlin site.

Commenting on the signing of the Agreement, Laidlaw Berlin BioPower, LLC President and CEO Michael Bartoszek stated "We have spent considerable time negotiating this acquisition and we are very pleased with the outcome. Berlin has all of the elements of a highly successful project. We look forward to closing the acquisition as soon as possible and moving forward with the further development and construction of the project."

ABOUT THE BERLIN, NH BIOMASS-ENERGY PROJECT

The Berlin project involves the conversion of the former Fraser Paper pulp mill site into a highly advanced biomass-to-energy project that is expected to export approximately 60 megawatts of renewable energy to the New England power grid and utilize over 700,000 tons of clean wood biomass chips per annum. The project involves a capital investment of approximately $100 million and is expected to employ 40 directly and create over 500 indirect jobs. Once completed, the plant is expected to be the largest and among the most environmentally advanced biomass-energy plants in North America.

INNOLIFE PHARMA INCORPORATED (OTC: INNP) "Up 267.65% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/INNP.php

Innolife Pharma Inc.'s unique evidence-based and clinically proven centralized pain model approach focuses on reversing the endorphin, serotonin and other significant neurotransmitter pain killer depletion found in chronic pain sufferers. This results in significant long-lasting pain, insomnia and depression relief in your patients without the need for narcotics, drugs, surgery or ongoing supplementation.

INNP News:

May 12 - Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture

Innolife Pharma, Inc. (OTC: INNP) has been in discussion over the previous eight months regarding the formation of a joint venture partnership. INNP has reached a point in these negotiations where final written terms have been submitted on all key issues which could lead to the Company's very first product acquisition. It should be noted that this process evolved methodically over this extended period due to the successful, long term history of the product involved, and the well-established reputation of its founding corporation.

Management anticipates additional forthcoming news and progress updates on the closing of this transaction that can complete great strides in two specific areas. One is the awarding of valuable rights to Innolife Pharma of an industry leading product. This established brand known for innovation and consistency over more than two decades can be launched in a brand new target market for the first time representing the largest market of this type on a global scale. Secondly, but of equal importance, is the solidifying of a joint venture with a partner of great quality and experience. The intention is to unite the market access and distribution capabilities of INNP with the knowledge, leadership, and existing contacts of our potential joint venture partner.

INNP will continue to reveal details of our aggressive strategy geared towards long term growth as they become available. We are confident that a partnership will emerge and start to bring in revenue in the near term based on the high level of negotiations reached with an industry leader in the information technology field. The Company believes that the size of our target market is potentially in excess of US$20 Billion. Updates will also be available on the Company's official corporate web site at www.innolifepharma.com.

CYCLONE POWER TECHNOLOGIES (OTC: CYPW) "Up 35.29% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CYPW.php

Cyclone holds the U.S. patent, international patent applications, and exclusive commercial rights to the Cyclone Engine, an environmentally friendly and highly efficient external combustion, heat-regenerative engine. Developed by Cyclone's President and CEO, Harry Schoell, the Cyclone Engine regenerates (or recycles) its heat, which allows it to run cleaner, cooler and more efficiently than traditional internal combustion engines. The Cyclone Engine is capable of running on any liquid or gaseous fuel, including ethanol, bio-diesel and propane. The company also recently filed a patent application for its Waste Heat Engine, a low-pressure engine capable of running on heat emitted from external sources, including the waste exhaust of a power generator or renewable solar power. Both these engines are lubricated with de-ionized water instead of motor oil, and by eliminating many subsystems like oil pumps, radiators, catalytic converters and fuel injectors, the Cyclone Engines are expected to cost less to manufacture, operate and maintain. The Cyclone Engine is highly scalable and sufficiently powerful for applications ranging from lawn equipment and small home generators, large stand-alone generators, to cars, trucks, buses, RV's, boats and ships, as well as earth moving equipment and locomotives.

CYPW News:

May 12 - Cyclone Power Technologies Files Disclosure Statement

Cyclone Power Technologies Inc. (OTC: CYPW) filed its Disclosure Statement with the Pink Sheets Electronic OTC Markets. The Statement is a complete disclosure of the business, management, material agreements, capitalization and financial condition of the company, current through the most recent reporting period of March 31, 2008. Investors may view this filing on www.PinkSheets.com or www.OTCiq.com.

"We see great things for the future of our green engine technology," stated Cyclone's CEO, Harry Schoell. "As we grow and look to the capital markets, we want to make sure our shareholders have all the most current information they need to evaluate our business. We are working hard to build investor confidence."

DOUGLAS LAKE MINERALS (OTCBB: DLKM) "Up 18.42% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/DLKM.php

Douglas Lake Minerals is an emerging mineral exploration company focused on exploring and developing gold, copper, nickel, uranium and diamond mining opportunities in Tanzania. DLKM has a portfolio of 51 prospecting concessions and is negotiating to acquire an additional 80. For more information go to www.douglaslakeminerals.com.

DLKM News:

May 9 - Douglas Lake Minerals acquires massive 430 sq km alluvial gold deposit

Douglas Lake Minerals (OTCBB: DLKM) announced that it has concluded an agreement with a Tanzanian National who holds the mineral rights to four Prospecting Licenses (PL's). The PL's cover an area of 430 square kilometers, and are situated in Mbwemkuru in the Lindi Region in Southeastern Tanzania.

The area is situated in the SE margin of the Karoo Basin, where there is an interland paleo basin comprising greater than 10 meters of gold bearing gravel and sandy material. The property is currently in small-scale production by the current owner. One of the most significant prospects being a 8 km by 2km block, with high gold concentrations within 1.0 and 1.5 meter zones between the gravel's and the bedrock. Another zone, a 3 by 4 kilometer block, is covered by over 9 meters thick of gravel and sandy material from surface to bedrock. In order to determine the upside potential pertaining to these placer deposits situated in this block a systematic exploration program is planned to commence on June 1, 2008.

On a recent site visit it became obvious that the area has significant potential. The closing date of the transaction should be on or before June 30, 2008.

ABOUT OTCPICKS.COM

OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover's Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.

Release of Liability:Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks is receiving nine thousand dollars directly from the company for CABN advertising and promotion services. OTCPicks.com has been compensated seven thousand dollars by a third party (Emerging Markets) for CYPW advertising and promotional services. For a complete list of disclosures go to http://www.otcpicks.com/disclosure_details.php. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled.

The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.

Third Party Web Sites and Information:

OTCPicks.com and newsletter may provide hyperlinks to third party websites or access to third party content. OTCPicks.com does not control, endorse, or guarantee content found in such sites. You agree that OTCPicks.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that OTCPicks.com shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

CONTACT: Brian Dean, Publisher, OTCPicks.com Tel: +1 972 546 3740 e-mail: publisher@otcpicks.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

(C)1994-2008 M2 COMMUNICATIONS LTD


Public Companies Associated with this story:
CABN CYPW DLKM INNP LLEG

Knobias Subject Codes Associated with this story:
Major Agreements Symbol/Name Change

Content transmitted by Knobias.com Copyright © 2008 Visit Knobias.com
http://www.knobias.com/story.htm?eid=3.1.9b3470af7ce5d6c4bb9fee0ab0c97c290e51531daed3bce9e7b1b06e9ede7404


ABOUT | PARTNERS | ADVERTISING INFO | CONTACT US | COPYRIGHT | PRIVACY | LEGAL | DISCLAIMER
Copyright © 2008 Knobias.Com, LLC. All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Knobias.Com, LLC, nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Knobias.Com website(s), a user agrees not to redistribute the information found therein. Knobias.Com, LLC is not a registered broker-dealer and does not endorse or recommend any securities listed herein or any services of any brokerage company.

Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture
Monday , May 12, 2008 07:30ET

http://www.knobias.com/story.htm?eid=3.1.7723a9534b7d35b47bf7f8c385fba79db794347edc7538a9c87f7de9df3be838

MARKHAM, ON, May 12 /PRNewswire-FirstCall/ - Innolife Pharma, Inc. (Other OTC:INNP.PK - News) has been in discussion over the previous eight months regarding the formation of a joint venture partnership. INNP has reached a point in these negotiations where final written terms have been submitted on all key issues which could lead to the Company's very first product acquisition. It should be noted that this process evolved methodically over this extended period due to the successful, long term history of the product involved, and the well-established reputation of its founding corporation.

Management anticipates additional forthcoming news and progress updates on the closing of this transaction that can complete great strides in two specific areas. One is the awarding of valuable rights to Innolife Pharma of an industry leading product. This established brand known for innovation and consistency over more than two decades can be launched in a brand new target market for the first time representing the largest market of this type on a global scale. Secondly, but of equal importance, is the solidifying of a joint venture with a partner of great quality and experience. The intention is to unite the market access and distribution capabilities of INNP with the knowledge, leadership, and existing contacts of our potential joint venture partner.

INNP will continue to reveal details of our aggressive strategy geared towards long term growth as they become available. We are confident that a partnership will emerge and start to bring in revenue in the near term based on the high level of negotiations reached with an industry leader in the information technology field. The Company believes that the size of our target market is potentially in excess of US$20 Billion. Updates will also be available on the Company's official corporate web site at www.innolifepharma.com. Please bear with us as the site is still under development, but will be officially launched upon finalization of our partnership and product acquisition.

FORWARD-LOOKING STATEMENTS:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.

SOURCE Innolife Pharma Inc.

Contacts:

Innolife Pharma, Inc.
(905) 943-4938
Email: info@innolifepharma.com


Public Companies Associated with this story:
INNP

Knobias Subject Codes Associated with this story:
Major Agreements

Content provided by PR Newswire Copyright © 2008
Content transmitted by Knobias.com Copyright © 2008 Visit Knobias.com

http://www.knobias.com/story.htm?eid=3.1.7723a9534b7d35b47bf7f8c385fba79db794347edc7538a9c87f7de9df3be838

ABOUT | PARTNERS | ADVERTISING INFO | CONTACT US | COPYRIGHT | PRIVACY | LEGAL | DISCLAIMER
Copyright © 2008 Knobias.Com, LLC. All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Knobias.Com, LLC, nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Knobias.Com website(s), a user agrees not to redistribute the information found therein. Knobias.Com, LLC is not a registered broker-dealer and does not endorse or recommend any securities listed herein or any services of any brokerage company.

INNP CHART

Company Info:
http://www.pinksheets.com/pink/quote/quote.jsp?symbol=innp

Lots of information on website.
http://www.innolifepharma.com/about.html

If you are looking for increased volume that is not too likely unless INNP starts diluting the stock. Per Scottrade, there is only 2 Million shares outstanding. A volume of 356,000 today is a large chunk of the outstanding shares.

I agree. MMs are buying all they can. I sold some at the Asked - .0625. If you have to sell, try at the Asked. It will be interesting to see if there is a large purchase after the close today, to cover all the shares sold during the day.

INNP: MMs definitely bidding for shares; sell orders going through yet BID increases toward EOD...next few days should be interesting, especially with some increased volume.

INNP looks like it will make an even larger move soon with the way the MMs are just sitting on the BID accumulating shares and the ASK is solid. GLA

Wow..step away for a couple years and the run is starting!
I am thinking 10 cents is not out of the question.

Last trade .0625. There are only $2 million shares shown as outstanding. That makes the market cap at about $120,000.

Bid - .05 Asked .055
At the current price of .05 the Market Cap is now only $100,000. A market Cap of only 1 Million Dollars would put the stock price at .50. Anyone think the price can go higher than .05?

Bid - 04 Asked - .05 Up 130% in less than an hour.

FINALLY, SOME NEWS:

http://biz.yahoo.com/prnews/080512/to284.html?.v=71

More to come.

INNP's post on AlphaRx is misleading. I spoke to a member of the team at AlphaRx and they said they no longer have anything to do with INNP.

So what is the direction if any? This is truly disappointing. At least type out a post telling us if you are in or out of business. I'm talking to you, Rita!

AlphaRx has taken back or is in the process of taking back Flexogan.
As a long standing and loyal shareholder of Rita's company, I recommend not purchasing one more share of Rita's company until she shows some good and logical direction and more importantly, some good earnings.

Innolife Pharma Inc. (otc: INNP) Stock Symbol:
Knobias MEMBERS get: Quotes | Charts | Technical Analysis | Quick Profiles | EDGAR Filings | News & Alerts | TearSheet Profiles | Historical Statistics | Insider Transactions | Institutional Holdings | ...and Much More
http://www.knobias.com/individual/public/quote.htm?ticker=INNP

http://www.knobias.com/individual/public/quote.htm?ticker=INNP


Last Trade: 0.015 Change: -0.005 ( -25.000 %)



Previous Close: 0.020 Today's Open: 0.013



# of Trades: 6 Volume: 51,000



Avg. # of Trades: 2 Avg. Daily Volume: 11,252





Bid: N/A Bid Size: N/A



Ask: N/A Ask Size: N/A



Day High: 0.015 Day Low: 0.012



52 Week High: 0.050 52 Week Low: 0.010



Market Cap: 127.50K Dividend: N/A



EPS: N/A P/E Ratio: N/A





RAiDAR alerts Learn More About RAiDAR-LT


08/24/2007 (17:38 ET) INNP: Short Interest UNCHG at 1 in Aug 2007 - Knobias



07/24/2007 (18:56 ET) INNP: Short Interest UP 100.0% to 1 in Jul 2007 - Knobias



06/26/2007 (16:39 ET) INNP: Short Interest DN 100.0% to 0 in Jun 2007 - Knobias



05/25/2007 (01:12 ET) INNP: Short Interest DN 99.9% to 5 in May 2007 - Knobias



05/02/2007 (11:47 ET) AAGR: Commences Name Change to Better Reflect Company Direction - Knobias



05/02/2007 (11:43 ET) Anti Aging Medical Group Corp. Announces Name and Symbol Change - Market Wire



05/02/2007 (06:45 ET) Symbol/Name Changes Expected for May 2, 2007 - Knobias



04/24/2007 (18:01 ET) AAGR: Short Interest UP 704.1% to 8.7K in Apr 2007 - Knobias



04/11/2007 (11:15 ET) AAGR: New 52-Wk Low @ $0.019 dn 5% - Knobias



03/26/2007 (16:46 ET) AAGR: Short Interest UP 100.0% to 1.1K in Mar 2007 - Knobias



03/09/2007 (06:45 ET) Symbol Changes Expected for March 9, 2007 - Knobias



03/08/2007 (16:38 ET) AAGM: Announces Reverse Split - Knobias



03/08/2007 (16:34 ET) Anti Aging Medical Group Corp. Announces Reverse Split - Market Wire



03/08/2007 (14:50 ET) AAGM: Sets 1-250 Reverse Stk Split; Eff Mar 09 - Knobias



03/08/2007 (14:50 ET) AAGM: 1-250 Reverse Stk Split Eff Friday, Mar 09 - Knobias



03/08/2007 (04:36 ET) Anti Aging Medical Group Corp. Announces Reverse Split - Filing Services Canada



01/24/2007 (17:00 ET) AAGM: Short Interest DN 100.0% to 0 in Jan 2007 - Knobias



01/23/2007 (08:30 ET) Anti Aging Medical Group Corp. Reports Corporate Milestones - Market Wire



01/23/2007 (08:30 ET) Anti Aging Medical Group Corp. Reports Corporate Milestones - Filing Services Canada



12/27/2006 (20:00 ET) AAGM: Short Interest UP 100.0% to 1.6K in Dec 2006 - Knobias



11/15/2006 (09:45 ET) Anti Aging Medical Group Corp. Provides Corporate Update - Market Wire



11/15/2006 (00:00 ET) Anti Aging Medical Group Corp. Provides Corporate Update - Filing Services Canada



11/10/2006 (10:56 ET) Daily Newsletter (QualityStocks.net) - 3rd Party Opinions



11/09/2006 (10:31 ET) AAGM/ALRX: Collaboration Agreement for Development of Compound for Alzheimer's - Knobias



11/09/2006 (00:00 ET) Anti Aging Medical Group Corp. Establishes Collaboration with AlphaRx and Leading Neurologists for Alzheimer's Disease - Filing Services Canada



company profile

Innolife Pharma Inc.is a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically proven products that offer both health maintenance and appearance enhancing benefits to all of us. Nutraceuticals are products that have multiple benefits in terms of revitalization for vision, prostate, bone and joint care as well as memory improvement. The Company is developing a drug delivery based, proprietary, non-prescription topical and oral product line which is fast becoming the industry's leader in the treatment of age resistance. Cosmeceuticals are skin care products which are specifically designed to enhance the appearance of your skin while catering to its needs. ... MORE INFO

CONTACT: Rita Sung (PR/CEO/DIR)
Innolife Pharma Inc.
7030 Woodbine Ave
Suite # 500
Markham, ON L3R 6G2
P: (905) 943-4938
F: (501) 636-9647
Company Home Page | Email

Industry: Drugs
SIC: 2834
Employees: 0
Locations: 1

State of Inc: DELAWARE 2002
Development Stage? Transfer Agent:
Select American Transfer Co
Toronto, ON M2N 7G2

Investor Relations:


Authorized Shares: 600,000,000
Source: Company Website ( 04/10/2006 )

Outstanding Shares: 8,500,000
Source: Stock Split ( 03/09/2007 )

Fiscal Year End:

MANAGEMENT & INSIDERS:


Need More Stock Research?

http://www.knobias.com/individual/public/quote.htm?ticker=INNP


ABOUT | PARTNERS | ADVERTISING INFO | CONTACT US | COPYRIGHT | PRIVACY | LEGAL | DISCLAIMER

Copyright © 2007 Knobias.Com, LLC. All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Knobias.Com, LLC, nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Knobias.Com website(s), a user agrees not to redistribute the information found therein. Knobias.Com, LLC is not a registered broker-dealer and does not endorse or recommend any securities listed herein or any services of any brokerage company.
http://www.knobias.com/individual/public/quote.htm?ticker=INNP

INNP - INNOLIFE PHARMA (OTC)

http://quotes.barchart.com/quote.asp?sym=INNP

Date Open High Low Last Change Volume % Change  
 12/11/07 0.0130 0.0150 0.0120 0.0150 unch 51000 unch %  
 12/10/07 0.0150 0.0150 0.0150 0.0150 unch 5000 unch %  
 12/07/07 0.0150 0.0150 0.0150 0.0150 +0.0050 20000 +50.00 %  
 12/06/07 0.0100 0.0100 0.0100 0.0100 -0.0050 400 -33.33 %  
 12/04/07 0.0150 0.0150 0.0150 0.0150 unch 13900 unch %  
  
 -- Period --  -- High --  -- Low --   
 5-Day  0.0150 on 12/11/07 0.0100  on 12/06/07   
 20-Day  0.0200  on 11/21/07  0.0100  on 11/14/07   
 65-Day  0.0200  on 09/27/07  0.0100  on 09/24/07   
 100-Day  0.0200  on 07/31/07  0.0100  on 08/30/07   
 260-Day  0.0500  on 05/02/07  0.0100  on 08/30/07   
 Year to Date  0.0500  on 05/02/07  0.0100  on 08/30/07   
  
  
 For The Last  Made New High  Percent From  Made New Low  Percent From   
 5 days 2 time(s) unch % 1 time(s) +50.00 %  
 20 days 2 time(s) -25.00 % 1 time(s) +50.00 %  
 65 days 3 time(s) -25.00 % 2 time(s) +50.00 %  
 100 days 2 time(s) -25.00 % 3 time(s) +50.00 %  
 260 days 1 time(s) -70.00 % 7 time(s) +50.00 %  
 Year to Date 1 time(s) -70.00 % 7 time(s) +50.00 %

INNP CHART*

Momentum beginning to start!!!!!!!!!

Yup.Small float and any big volume should take this to .05 Imo.

There is life in this loser. Vol 53 x avg vol and the pps +70%. I expect a pump to start soon. Jim

Contact Us
AlphaRx Life Sciences Limited
610 Nathan Road
Suite 618, Hollywood Plaza
Kowloon, Hong Kong

Phone: 2165-4172
Fax: 3007-8579
Email: info@flexogan.com.hk

FOR IMMEDIATE RELEASE
FLEXOGAN. THE OFFICIAL PAIN RELIEF
of the 2004 BELL CANADIAN OPEN
TORONTO, CANADA – August 4, 2004 -- Flexogan™ is the Official Pain
Relief Sponsor of the 2004 Bell Canadian Open, being held at the prestigious Glen
Abbey Golf Club in Oakville, Ontario, from September 6 to 12.
“We are thrilled to be a part of this year’s Bell Canadian Open. On behalf of the
AlphaRx team, we congratulate all players and extend our best wishes for another
successful year to everyone involved. We also welcome all who will attend to visit our
Flexogan tent,” says Michael M. Lee, President & CEO, AlphaRx.
Flexogan™, topical pain relief creams are AlphaRx’s first over-the-counter product line,
and are available at leading grocery and drug retailers in Canada. Flexogan’s unique
patented ‘nano technology’ penetrates deeply into the skin for fast, effective and long
lasting relief from Arthritis, Joint and Muscle Pain.
Flexogan's BCD™ (Bioadhesive Colloidal Dispersion) composition, proprietary to
AlphaRx, consists of highly dispersed oil droplets loaded with natural menthol and
camphor. The droplet size is less than 1 micron, 10 to 20 times smaller than the leading
topical analgesic creams, carrying Flexogan’s other powerful, active ingredients directly
to the source of your pain. Relief is more immediate, so you can use less and reapply
less often.
Flexogan is non-greasy and contains Vitamin E and skin protective emollients which,
because of their high bioavailability, leave skin smooth and free of irritation. Flexogan is
highly effective, yet safe for ages 2+.
“We started AlphaRx to pioneer the research and development of effective and
innovative medicines and drug delivery platforms to enhance people’s health, longevity
and quality of life. As an active baby boomer, I realized a number of years ago that I was
among a large demographic whose lifestyles were impeded by a lack of effective
medications. Consequently, we focused on a number of wellness-specific products, all
based on the same innovative delivery technology. Flexogan, our answer to sore
muscles, joints and arthritic pain, is our first product line to be available over-the-counter
to the consumer”, says Michael M. Lee, President & CEO, AlphaRx.
2
AlphaRx offers a full range of Flexogan pain relief creams to meet consumer needs:
FLEXOGAN ARTHRITIS PAIN: Is a unique BCD™ formula with Methyl Salicylate that
penetrates deep at the site of application to provide fast, effective and long lasting relief
from Arthritis, Joint and Muscle Pain. Available in 50g and 100g tubes. Suggested
retail prices: 50g $9.95, 100g $14.94.
FLEXOGAN MUSCLE PAIN: Is a unique BCD™ formula that penetrates deep at the
site of application to provide fast and effective relief from Sore and Strained Muscles,
Backache, Minor Arthritis & Joint Pain. Available in 50g and 100g tubes. Suggested
retail prices: 50g $7.99, 100g $11.99.
FLEXOGAN SPORT: Is a unique BCD™ formula with herbal extracts. It contains
Vitamin E, Chamomile C02 Extract and skin protective emollients which, because of
their high bioavailability, leave the skin smooth and free of irritation.
It penetrates deep at the site of application to provide fast, effective and long lasting
relief from Arthritis, Joint and Muscle Pain. Available in 150g jars. Suggested retail
price for 150g jar $17.95.
FLEXOGAN SPORT ULTRA: Is a unique BCD™ formula that has all of the active
ingredients of Flexogan Sport with the addition of Methyl Salicylate.
It penetrates deep at the site of application to provide fast, effective and long lasting
relief from Arthritis, Joint and Muscle Pain. Available in 150g jars.
Suggested retail price for 150g jar $22.95.
Flexogan is the Official Pain Relief Supplier of this years’ Bell Canadian Open and
BMO Financial Group Canadian Women’s Open. Flexogan is also a Gold Dragon
Sponsor of the Toronto International Dragon Boat Race Festival, and a TrekPoint
Sponsor of The Lung Association’s BikeTrek event in York region. AlphaRx’s
marketing, advertising and PR for these events has been handled by, The Ink Tank Inc.
of Toronto. www.theinktank.com.
AlphaRx is an emerging research-based biopharmaceutical and healthcare company. It
utilizes proprietary ‘nano delivery technology’ to formulate effective over-the-counter
and prescription products. AlphaRx is committed to improving the health and overall
quality of life for people of all ages through its charitable giving program.
Visit www.alpharx.com.
AlphaRx © 2004
-30-
For media inquiries and interview requests:
Peter Ashworth
416 603-6005
ashworth.associates@sympatico.ca

I am now starting to believe this is a scam. I have emailed, phoned, etc. for months. I like to believe that companies do not reply until they have something to report or they are in the middle of restructuring.

The phone number given to us for Markham, Ontario, Canada is simply an answering service. The receptionist has no information.

Rita...come out, come out, where ever you are...

If you are going to fold the company, fold it and get the lawsuits over with.

If you are going to proceed with a viable company, by all means, let us know.

Where is that loser CEO that abandon us for months now.R/S us and still down the tubes after R/S????

Yes what u say is correct about disclaimer ,"that all the info may not be accurate...."But there is different between inaccuracy and false and fake PRs.
What I know is that: in this country you cannot cheat easily and runaway with that even at the level of ENRON's CEO .
Anyway I am ready to start it if others are having the same idea and it is confirmed that we have been scammed.

Beside all these things I hope that your health is going ok and enjoying in florida.I am living in atlanta and things are as usual as always.

I'm very well....thanks for asking.....living in Florida, now....class action is the way to go.....and, i'm so fed up with all the nonsense in "Pinkyland" that I would be willing to jump on the class action wagon.....question is: are misleading PR's enough.....remember, they attach a disclaimer to each of them which essentially says that all the info may not be accurate....

Hey Geo how r u man ....long time no hear from u.
As you know when a company registered here in U.S and their stocks are traded in new york exchnange It means that there will be traceable individuals behind it.
Next is whether the company has failed in their aimes or the company has deceived the investors with FALSE AND FAKE PRs ,which in our case it look like the latter.
You asked me who exactly can catch them??I tell you investors(together) can do by class action and that wont be hard since we have proof of their false PRs.
And I willbe the one ready for that if others also interested.

.....and, who, exactly, will catch them????

Well to me it is more look like a scam!!!
not even one of their PRs were true!!

New site...,persuing new alzhiemer drug...marketing their products in U.S..... ,Openning an office in hong kong.....etc.

If they were faking it then soon or later they willbe caught.

looks like it

Did Rita turn the lights out on the way out with the money?

It is better not to supply news when there isn't any. This company must get thousands of emails due to the fact that they don't reply to anyone. Hopefully, they are not running a scam.

However, I received an email (can't remember name) and he said that there is good news on the way. I was kind of shocked to receive this email because I sent many.

Anyway, I am hoping there is some good news for us.

If there is news on heavy product sales, the stock will not jump pennies, dimes or nickels. It will jump in values of dollars. Why? I have said it over and over again...only 8 million shares!

I believe that someone in this company knows something and the reverse split might prove this to be true.

An even better thing for INNP to do would be to get the price up where it belongs and then move to another more reputable stock exchange.

i agree but news was supposed to be give like 2 months ago after the r/s.. still nothing from the company

All is not lost. With the reverse split, there are fewer shares and it will only take some positive news on product to make the stock pop. The key here is 8 million shares. No supply...pure demand!

well i guess the only ou of this stock is a) they give us some good news or someone pumps the crap out of it.. either way i think i would be happy

http://www.investorshub.com/boards/read_msg.asp?message_id=20626721

What the heck has happened here?! Was this just another scam? Did Rita spend all of our money in Vegas and then disappear?

Geez...just another stock for my investment graveyard. I don't even want to take the effort to sell it because the fee will be more than the sale is worth...if anyone would even buy it that is.

How disappointing.

For Innolife Pharma as of 5-17-2007 there were 8,467,000 shares outstanding with 6,053,000 shares free trading and 2,414,000 shares restricted and 3,000,000,000 shares authorized.

Thank you

Jason M. Bogutski - President
Signature Stock Transfer, Inc.
2301 Ohio Drive - Suite 100
Plano, Texas 75093

Telephone Number 972 612 4120
Facsimile Number 972 612 4122
Email Address signaturestocktransfer@msn.com